EMMA (Emmaus Life Sciences) Inventory Turnover: 0.10 (As of Mar. 2026)

What is Emmaus Life Sciences Inventory Turnover?

Emmaus Life Sciences EMMA Inventory Turnover is 0.10 as of Mar. 2026. The stock has 6 warning signs investors should review.

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. Emmaus Life Sciences's Cost of Goods Sold for the three months ended in Mar. 2026 was $0.17 Mil. Emmaus Life Sciences's Average Total Inventories for the quarter that ended in Mar. 2026 was $1.73 Mil. Emmaus Life Sciences's Inventory Turnover for the quarter that ended in Mar. 2026 was 0.10.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Emmaus Life Sciences's Days Inventory for the three months ended in Mar. 2026 was 940.74.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Emmaus Life Sciences's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 0.87.

Emmaus Life Sciences (OTCPK:EMMA) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Emmaus Life Sciences's Days Inventory for the three months ended in Mar. 2026 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Mar. 2026 )	/	Cost of Goods Sold (Q: Mar. 2026 )	*	Days in Period
	=	1.732	/	0.168	*	365 / 4
	=	940.74

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Emmaus Life Sciences's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Mar. 2026 )	/	Revenue (Q: Mar. 2026 )
	=	1.732	/	1.982
	=	0.87

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.

Emmaus Life Sciences Inventory Turnover Related Terms

Emmaus Life Sciences Inventory Turnover Historical Data

* Premium members only.

The historical data trend for Emmaus Life Sciences's Inventory Turnover can be seen below:

Emmaus Life Sciences Inventory Turnover Chart

Emmaus Life Sciences Annual Data

Trend

Sep16

Sep17

Sep18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Inventory Turnover

Get a 7-Day Free Trial

0.58

0.76

0.66

0.72

0.54

Emmaus Life Sciences Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Inventory Turnover	Get a 7-Day Free Trial															0.15	0.11	0.20	0.17	0.10

Emmaus Life Sciences Inventory Turnover Calculation

Emmaus Life Sciences's Inventory Turnover for the fiscal year that ended in Dec. 2025 is calculated as

	Inventory Turnover (A: Dec. 2025 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (A: Dec. 2025 )	/ (	(Total Inventories (A: Dec. 2024 )	+	Total Inventories (A: Dec. 2025 ))	/	count )
=	0.857	/ (	(1.635	+	1.555)	/	2 )
=	0.857	/	1.595
=	0.54

Emmaus Life Sciences's Inventory Turnover for the quarter that ended in Mar. 2026 is calculated as

	Inventory Turnover (Q: Mar. 2026 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (Q: Mar. 2026 )	/ (	(Total Inventories (Q: Dec. 2025 )	+	Total Inventories (Q: Mar. 2026 ))	/	count )
=	0.168	/ (	(1.555	+	1.909)	/	2 )
=	0.168	/	1.732
=	0.10

Frequently Asked Questions Learn more about Inventory Turnover →

What does a Inventory Turnover of 0.10 mean?

Emmaus Life Sciences (EMMA) has a Inventory Turnover of 0.10 as of Mar. 2026. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on Emmaus Life Sciences and its competitors.

Is Emmaus Life Sciences' Inventory Turnover too high?

Emmaus Life Sciences' current Inventory Turnover is 0.10.

How does Emmaus Life Sciences' Inventory Turnover compare to PTIX and BZYR?

Emmaus Life Sciences' Inventory Turnover of 0.10 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Inventory Turnover for a Biotechnology company?

A good Inventory Turnover depends on the Biotechnology industry context. However, Inventory Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Inventory Turnover mean?

A high Inventory Turnover can signal that a stock is expensive relative to its fundamentals. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on Emmaus Life Sciences and its competitors. Emmaus Life Sciences's current Inventory Turnover is 0.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Emmaus Life Sciences stock overvalued right now?

Based on GuruFocus' analysis, Emmaus Life Sciences (EMMA) is currently considered Fairly Valued. The stock's GF Value™ is $0.01, compared to a current price of $0.01 — trading right at its estimated fair value. The current Inventory Turnover is 0.10. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Inventory Turnover calculated?

Inventory Turnover is calculated from a company's financial statements. For Emmaus Life Sciences (EMMA), the current Inventory Turnover is 0.10 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Emmaus Life Sciences Business Description

Industry Healthcare Biotechnology

Comparable Companies PTIX BZYR RMTG AGTX CERO ATXI WINT LIPO CLSDQ IOBTQ VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Address 21250 Hawthorne Boulevard, Suite 800, Torrance, CA, USA, 90503

Website https://www.emmausmedical.com

Emmaus Life Sciences Inc is a commercial-stage biopharmaceutical company engaged in the discovery, development, marketing and sales of the Company's product Endari (prescription grade L-glutamine oral powder), to reduce the acute complications of sickle cell disease (SCD) in adult and pediatric patients five years of age and older. Endari is reimbursable by the Centers for Medicare and Medicaid Services, and every state provides coverage for Endari for outpatient prescriptions to all eligible Medicaid enrollees within their state Medicaid programs. Endari is also reimbursable by many commercial payors.